• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115

• Solvents and Organic Chemicals Organic Compounds Benzenoids Tetralins Tetralins
• Solvents and Organic Chemicals Organic Compounds Benzenoids Tetralins

Introduction to 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- (CAS No. 31706-56-6)

2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- (CAS No. 31706-56-6) is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, characterized by its naphthalene core with hydroxyl and methyl substituents, has garnered attention due to its versatile structural framework and potential biological activities. The presence of the dihydro moiety and the methyl group at the 7-position imparts unique electronic and steric properties, making it a valuable scaffold for further chemical modifications and functionalization.

The compound belongs to the class of naphthalenone derivatives, which are widely studied for their pharmacological properties. Naphthalenone derivatives have been explored for their roles in various therapeutic applications, including anti-inflammatory, antimicrobial, and anticancer agents. The structural features of 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- make it an attractive candidate for medicinal chemistry investigations.

In recent years, there has been a surge in research focusing on developing novel heterocyclic compounds with potential therapeutic benefits. The naphthalenone scaffold is particularly interesting because it can be easily modified to create a wide range of derivatives with distinct biological activities. For instance, studies have shown that substituents at specific positions on the naphthalenone ring can significantly alter the pharmacokinetic and pharmacodynamic properties of the compound.

One of the most compelling aspects of 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- is its potential as a precursor for more complex molecules. Researchers have leveraged this compound to synthesize novel analogs that exhibit enhanced biological activity. For example, modifications at the 3 and 4 positions have been shown to improve binding affinity to certain biological targets. This has led to the development of new drug candidates that are more potent and selective than their parent compounds.

The synthesis of 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- typically involves multi-step organic reactions that highlight the compound's structural complexity. Advanced synthetic methodologies, such as catalytic hydrogenation and cross-coupling reactions, are often employed to achieve high yields and purity. These synthetic routes not only demonstrate the compound's synthetic utility but also provide insights into its mechanistic properties.

Recent advancements in computational chemistry have further enhanced the understanding of 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl-'s behavior. Molecular modeling studies have been instrumental in predicting how different substituents affect the compound's electronic structure and reactivity. These predictions are crucial for designing experiments aimed at optimizing the compound's biological activity.

The pharmaceutical industry has taken note of the potential of naphthalenone derivatives like 2(1H)-Naphthalenone, 3,4-dihydro-7-methyl-. Several companies are currently engaged in developing drugs based on this scaffold. Early-stage clinical trials have shown promising results for certain derivatives in treating various diseases. These findings underscore the importance of continued research into this class of compounds.

In conclusion,2(1H)-Naphthalenone, 3,4-dihydro-7-methyl- (CAS No. 31706-56-6) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features make it an excellent candidate for further chemical modifications and biological studies. As research progresses, this compound is likely to play a crucial role in the development of new therapeutic agents that address unmet medical needs.

• 80270-88-8(2(1H)-Naphthalenone, 3,4-dihydro-5,8-dimethyl-)
• 1028202-76-7(6-octyl-3,4-dihydro-1h-naphthalen-2-one)
• 176236-91-2(2(1H)-Anthracenone, 3,4-dihydro-)
• 70855-13-9(2,5-Hexanedione,1-(4-methylphenyl)-)
• 31706-57-7(2(1H)-Naphthalenone,3,4-dihydro-6-methyl-)
• 150331-48-9(5,7-Dimethyl-2-tetralone)
• 34663-15-5(6,7,8,9-tetrahydro-5H-benzo7annulen-6-one)
• 37949-03-4(8,9-Dihydro-5H-benzo7annulen-7(6H)-one)
• 4242-15-3(5-Methyl-2-tetralone)
• 530-93-8(1,2,3,4-tetrahydronaphthalen-2-one)